Literature DB >> 18566317

Screening and assessment of coronary heart disease in HIV-infected patients.

Priscilla Y Hsue, Kathleen Squires, Ann F Bolger, Bernadette Capili, George A Mensah, Zelalem Temesgen, Christine A Wanke, David A Wohl.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18566317     DOI： 10.1161/CIRCULATIONAHA.107.189626

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  23 in total

1.  Progress in prevention: improving cardiovascular risk management among human immunodeficiency virus-positive individuals.

Authors:  Jason E Farley; Carrie Tudor; Cheryl R Dennison
Journal:  J Cardiovasc Nurs       Date:  2010 Jul-Aug       Impact factor: 2.083

2.  HIV and general cardiovascular risk.

Authors:  Bernadette Capili; Joyce K Anastasi; Olugbenga Ogedegbe
Journal:  J Assoc Nurses AIDS Care       Date:  2011-02-01       Impact factor: 1.354

Review 3.  Antiretroviral treatment interruptions and risk of non-opportunistic diseases.

Authors:  Kenneth A Lichtenstein
Journal:  Curr HIV/AIDS Rep       Date:  2009-05       Impact factor: 5.071

Review 4.  Noninvasive assessment of HIV-related coronary artery disease.

Authors:  Louis H Miller; John T Coppola
Journal:  Curr HIV/AIDS Rep       Date:  2011-06       Impact factor: 5.071

Review 5.  Coronary Artery Calcium: Recommendations for Risk Assessment in Cardiovascular Prevention Guidelines.

Authors:  Mahmoud Al Rifai; Miguel Cainzos-Achirica; Sina Kianoush; Mohammadhassan Mirbolouk; Allison Peng; Josep Comin-Colet; Michael J Blaha
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-09-26

6.  Cost-effectiveness analysis of coronary artery disease screening in HIV-infected men.

Authors:  Julia E H Nolte; Till Neumann; Jennifer M Manne; Janet Lo; Anja Neumann; Sarah Mostardt; Suhny Abbara; Udo Hoffmann; Thomas J Brady; Juergen Wasem; Steven K Grinspoon; G Scott Gazelle; Alexander Goehler
Journal:  Eur J Prev Cardiol       Date:  2013-03-28       Impact factor: 7.804

Review 7.  Role of Coronary Calcium for Risk Stratification and Prognostication.

Authors:  Negin Nezarat; Michael Kim; Matthew Budoff
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

8.  Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.

Authors:  Alexandra Mangili; Raabia Ahmad; Robert L Wolfert; Jeffrey Kuvin; Joseph F Polak; Richard H Karas; Christine A Wanke
Journal:  Clin Infect Dis       Date:  2013-12-11       Impact factor: 9.079

Review 9.  Exercise therapy for human immunodeficiency virus/AIDS patients: Guidelines for clinical exercise therapists.

Authors:  Jeanne M Grace; Stuart J Semple; Susan Combrink
Journal:  J Exerc Sci Fit       Date:  2015-01-29       Impact factor: 3.103

10.  Association of C-reactive protein and HIV infection with acute myocardial infarction.

Authors:  Virginia A Triant; James B Meigs; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.